4-hydroxypipecolic acid: an N-methyl-D-aspartate receptors agonist; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 151907 |
SCHEMBL ID | 1512969 |
MeSH ID | M0250022 |
Synonym |
---|
4-hydroxypipecolic acid |
1622-20-4 |
14228-16-1 |
4-hydroxypiperidine-2-carboxylic acid |
trans-4-hydroxy-(s)-pipecolic acid-4-sulfate |
2-piperidinecarboxylic acid, 4-hydroxy- |
ti2y2v33cq , |
4-hydroxy-2-piperidinecarboxylic acid |
unii-ti2y2v33cq |
t-hpis |
AKOS006310561 |
AB55088 |
SCHEMBL1512969 |
p-hydroxypipecolic acid |
4-hydroxy-dl-pipecolic acid |
ZB0512 |
FT-0771737 |
DTXSID60931402 |
4-hydroxypiperidine-2-carboxylicacid |
F53697 |
Q27289977 |
SB45148 |
SB41626 |
SB41643 |
SB47782 |
SB47775 |
CS-0446374 |
BAA62220 |
EN300-197513 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |